JournalsHub
.online
Find My Journal
RF

Ronan Flippot

Centre National de la Recherche Scientifique FR

ORCID 0000-0003-0083-4753
436
Publications
2,779
Citations
26
H-Index
49
i10-Index
0.59
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

436 total

Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma PDF

David A. Braun, Ziad Bakouny, Laure Hirsch, Ronan Flippot, Eliezer M. Van Allen et al. - Nature Reviews Clinical Oncology, 2021
Cited by 375 OpenAlex

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma PDF

Ziad Bakouny, David A. Braun, Sachet A. Shukla, Wenting Pan, Xīn Gào et al. - Nature Communications, 2021
Cited by 157 OpenAlex

Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma PDF

Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah, Wanling Xie, Ronan Flippot et al. - JAMA Oncology, 2021
Cited by 95 OpenAlex

Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma PDF

Elie Rassy, Ronan Flippot, Laurence Albigès - Therapeutic Advances in Medical Oncology, 2020
Cited by 136 OpenAlex

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group PDF

Lorenzo D’Ambrosio, Nathan Touati, Jean‐Yves Blay, Giovanni Grignani, Ronan Flippot et al. - Cancer, 2020
Cited by 135 OpenAlex

Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma

Laure Hirsch, Ronan Flippot, Bernard Escudier, Laurence Albigès - Drugs, 2020
Cited by 90 OpenAlex

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma PDF

Sarah Abou Alaiwi, Wanling Xie, Amin H. Nassar, Shaan Dudani, Dylan J. Martini et al. - Journal for ImmunoTherapy of Cancer, 2020
Cited by 83 OpenAlex

Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors PDF

Sarah Abou Alaiwi, Amin H. Nassar, Wanling Xie, Ziad Bakouny, Jacob E. Berchuck et al. - Cancer Immunology Research, 2020
Cited by 79 OpenAlex

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study PDF

Ronan Flippot, Cécile Dalban, Brigitte Laguerre, Delphine Borchiellini, Gwénaëlle Gravis et al. - Journal of Clinical Oncology, 2019
Cited by 160 OpenAlex

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features PDF

Bradley A. McGregor, Rana R. McKay, David A. Braun, Lillian Werner, Kathryn P. Gray et al. - Journal of Clinical Oncology, 2019
Cited by 143 OpenAlex

Research Topics

Cancer Immunotherapy and Biomarkers (167) Prostate Cancer Treatment and Research (163) Cancer Genomics and Diagnostics (143) Renal cell carcinoma treatment (138) Cancer, Lipids, and Metabolism (76)

Affiliations

Brigham and Women's Hospital
US 2023 - 2023
Centre National de la Recherche Scientifique
FR 2026 - 2023
City Of Hope National Medical Center
US 2023 - 2023
Inserm
FR 2026 - 2020
Université Paris-Saclay
FR 2026 - 2018

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now